How to Buy Cara Therapeutics Stock
Cara Therapeutics Inc
Cara Therapeutics, Inc. , an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States.
Cara Therapeutics stock last closed at $0.28, down 4.83% from the previous day, and has decreased 82.96% in one year. It has underperformed other stocks in the Biotechnology industry by 0.71 percentage points. Cara Therapeutics stock is currently +15% from its 52-week low of $0.24, and -83.57% from its 52-week high of $1.68.
There are currently 54.85M shares of CARA outstanding. The market value of CARA is $15.14M. In the past 24 hours, 197,785 CARA shares were traded.
How to Buy Cara Therapeutics Stock
Not sure how to invest in Cara Therapeutics stock? Here's how.
- Choose where to buy Cara Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Cara Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Select your payment method and add your information.
- Evaluate Cara Therapeutics stock: The Cara Therapeutics ticker symbol is CARA. Is Cara Therapeutics stock a good investment? Should you buy shares of CARA? How do CARA's underlying business fundamentals look? Do top analysts think Cara Therapeutics is a good buy? Why has CARA's stock price moved recently? (Hint: Our stock research website can help you understand if CARA is a good stock to buy).
- Make your CARA buy order: Decide if you will purchase CARA shares at the current market price or use a limit order to buy CARA shares at a given price.
- Get key alerts regarding your CARA position: Create a watchlist to track your position in Cara Therapeutics stock.
Step 1: Choose where to buy Cara Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy CARA shares.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in CARA today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open your new trading account.
- Send your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best app for stock investing, you need to deposit funds:
Watch the video below if you need help depositing funds into your new brokerage account.
Step 4: Evaluate Cara Therapeutics stock
After you have identified the best place to buy Cara Therapeutics stock, it's crucial to evaluate their stock before you buy, so you actually wrap your head around the risk as well as the opportunity.
Overview of key CARA info
Cara Therapeutics Zen Score
WallStreetZen was created to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on CARA's stock page.
What is the fair value of CARA stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CARA's true value.
Using relative valuations metrics:
- CARA may be undervalued based on its P/B ratio of 1.31x, relative to Biotechnology industry P/B ratio of 5.92x
You can do more valuation analysis on CARA's stock here.
Is CARA a healthy company?
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the CARA balance sheet.
- There are more short-term assets than long-term liabilities on the CARA balance sheet.
- CARA has $56.62M in cash and short term investments. This is sufficient to cover its annual cash burn of $83.33M.
Negative Financial Indicators:
- CARA has cash burn of 83326000. It does not have sufficient cash and short-term investments to cover this.
- CARA has a relatively high debt to equity ratio of 5.25.
- Total CARA debt is higher than 5 years ago, relative to shareholder equity.
- CARA profit margin has gone down from -410.9% to -1,010.2% in the past year.
Is it a good time to buy Cara Therapeutics stock, according to analysts?
Out of 3 sell side analysts who give ratings on CARA, the consensus analyst rating on Cara Therapeutics is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Cara Therapeutics stock forecast page.
CARA Technicals
How is CARA performing as a company?
Last year, CARA revenue was $11.00M. In the last 5 year, CARA's revenue has grown by -11.44% per year. This was slower than the Biotechnology industry average of 59.85%.
You can analyze CARA's earnings and revenue performance here.
Latest Insiders Trades at CARA
In the last year, executives and large shareholders at CARA have sold more shares than they have bought.
Christopher Posner, PRESIDENT AND CEO of CARA, was the latest CARA insider to sell. They sold $1,452.15 worth of CARA stock on Aug 1, 2024.
Dig into more about who owns CARA stock here.
Can I get consistent income from CARA stock?
No, Cara Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about CARA?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your CARA buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific price, place a limit order.
Click the Open button and your broker will execute your order.
If you want more help with investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your CARA position
Now that you own some CARA shares, you'll want to keep up with your new company.
Create a watchlist to get notified of important updates regarding your CARA stock.
CARA Feed
How to Buy Stock in Cara Therapeutics
To reiterate, here are the 6 steps to buy Cara Therapeutics stock:
- Choose where to buy Cara Therapeutics stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Cara Therapeutics stock
- Make your CARA buy order
- Get key alerts regarding your CARA position
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Cara Therapeutics, add CARA to your watchlist below.
More Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.